Changes to the website
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4842

Next 25
Website Changes
08/23/2016 Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.
08/18/2016 Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.
08/18/2016 Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
08/18/2016 Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
08/16/2016 Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
08/10/2016 Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.
08/10/2016 Call for chefs to enter Flo’s Chili Cook-Off
07/26/2016 NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
07/26/2016 International Study Finds Effective, Less Toxic Way to Treat Brain Tumors
07/26/2016 International Study Finds Effective, Less Toxic Way to Treat Brain Tumors
07/26/2016 Musella Foundation awards $149,992 in 3 brain tumor research grants.
07/26/2016 Musella Foundation Co-payment Assistance Program is now closed to new patients
07/25/2016 NCCN updated CNS cancer treatment guidelines to include Optune
07/25/2016 Musella Foundation Co-payment Assistance Program about to close to new patients
07/23/2016 DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016
07/23/2016 Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival
07/21/2016 PD-1 blockade enhances the vaccination induced immune response in glioma
07/16/2016 Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics
07/13/2016 Novocure Receives FDA Approval for Second Generation Optune System
07/13/2016 Musella Foundation Request for Donations!
07/06/2016 New microfluidic device offers means for studying electric field cancer therapy
07/05/2016 FDA Grants Accurexa Pre-IND Meeting for its ACX-31 Program in the Treatment of Brain Cancer
07/04/2016 Scientists just discovered we`ve been looking at cancer growth all wrong. This could change everything.
07/02/2016 Questions and Answers on the New Study Linking Cellphones and Cancer in Rats

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites